58 related articles for article (PubMed ID: 28642038)
1. Functional characterization of 21 allelic variants of dihydropyrimidinase.
Hishinuma E; Akai F; Narita Y; Maekawa M; Yamaguchi H; Mano N; Oda A; Hirasawa N; Hiratsuka M
Biochem Pharmacol; 2017 Nov; 143():118-128. PubMed ID: 28642038
[TBL] [Abstract][Full Text] [Related]
2. Functional Characterization of 12 Dihydropyrimidinase Allelic Variants in Japanese Individuals for the Prediction of 5-Fluorouracil Treatment-Related Toxicity.
Hishinuma E; Narita Y; Rico EMG; Ueda A; Obuchi K; Tanaka Y; Saito S; Tadaka S; Kinoshita K; Maekawa M; Mano N; Nakayoshi T; Oda A; Hirasawa N; Hiratsuka M
Drug Metab Dispos; 2023 Feb; 51(2):165-173. PubMed ID: 36414408
[TBL] [Abstract][Full Text] [Related]
3. Structural investigation of pathogenic variants in dihydropyrimidinase using molecular dynamics simulations.
Kato K; Nakayoshi T; Nagura A; Hishinuma E; Hiratsuka M; Kurimoto E; Oda A
J Mol Graph Model; 2022 Dec; 117():108288. PubMed ID: 35961217
[TBL] [Abstract][Full Text] [Related]
4. Common dihydropyrimidinase ( DPYS ) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort.
Medwid SJ; Mailloux JL; Wigle TJ; Kim RB
Pharmacogenet Genomics; 2024 Apr; 34(3):83-87. PubMed ID: 38215018
[TBL] [Abstract][Full Text] [Related]
5. The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity.
De Mattia E; Polesel J; Silvestri M; Roncato R; Scarabel L; Calza S; Spina M; Puglisi F; Toffoli G; Cecchin E
Hum Genomics; 2023 Nov; 17(1):99. PubMed ID: 37946254
[TBL] [Abstract][Full Text] [Related]
6. Importance of Rare
Hishinuma E; Narita Y; Obuchi K; Ueda A; Saito S; Tadaka S; Kinoshita K; Maekawa M; Mano N; Hirasawa N; Hiratsuka M
Front Pharmacol; 2022; 13():930470. PubMed ID: 35784703
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of dihydropyrimidinase in complex with anticancer drug 5-fluorouracil.
Huang YH; Ning ZJ; Huang CY
Biochem Biophys Res Commun; 2019 Oct; 519(1):160-165. PubMed ID: 31481233
[TBL] [Abstract][Full Text] [Related]
8. Dihydropyrimidinase protects from DNA replication stress caused by cytotoxic metabolites.
Basbous J; Aze A; Chaloin L; Lebdy R; Hodroj D; Ribeyre C; Larroque M; Shepard C; Kim B; Pruvost A; Moreaux J; Maiorano D; Mechali M; Constantinou A
Nucleic Acids Res; 2020 Feb; 48(4):1886-1904. PubMed ID: 31853544
[TBL] [Abstract][Full Text] [Related]
9. A novel stop-gain mutation in DPYS gene causing Dihidropyrimidinase deficiency, a case report.
Mirzaei M; Kavosi A; Sharifzadeh M; Mahjoub G; Faghihi MA; Habibzadeh P; Yavarian M
BMC Med Genet; 2020 Jun; 21(1):138. PubMed ID: 32600357
[TBL] [Abstract][Full Text] [Related]
10. Impact of DPYD, DPYS, and UPB1 gene variations on severe drug-related toxicity in patients with cancer.
Yokoi K; Nakajima Y; Matsuoka H; Shinkai Y; Ishihara T; Maeda Y; Kato T; Katsuno H; Masumori K; Kawada K; Yoshikawa T; Ito T; Kurahashi H
Cancer Sci; 2020 Sep; 111(9):3359-3366. PubMed ID: 32619063
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Assessment of Fluoropyrimidine-Metabolizing Enzymes: Dihydropyrimidine Dehydrogenase, Dihydropyrimidinase, and β-Ureidopropionase.
Hishinuma E; Gutiérrez Rico E; Hiratsuka M
J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32707991
[TBL] [Abstract][Full Text] [Related]
12. Structure, catalytic mechanism, posttranslational lysine carbamylation, and inhibition of dihydropyrimidinases.
Huang CY
Adv Protein Chem Struct Biol; 2020; 122():63-96. PubMed ID: 32951816
[TBL] [Abstract][Full Text] [Related]
13. Dihydropyrimidinase deficiency with atrioventricular septal defect: a case report.
Erdal İ; Yıldız Y; Kuseyri Hübschmann O; Haas D; Günbey C; Ertuğrul İ; Yalnızoğlu D
J Pediatr Endocrinol Metab; 2024 Jul; ():. PubMed ID: 38958169
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic odyssey of a patient with dihydropyrimidinase deficiency: a case report and review of the literature.
Albokhari D; Alharbi O; Blesson A; Jain M
Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 38199782
[TBL] [Abstract][Full Text] [Related]
15. An improved LC-MS method to profile molecular diversity and quantify the six main bovine milk proteins, including genetic and splicing variants as well as post-translationally modified isoforms.
Miranda G; Bianchi L; Krupova Z; Trossat P; Martin P
Food Chem X; 2020 Mar; 5():100080. PubMed ID: 32123868
[TBL] [Abstract][Full Text] [Related]
16. Molecular Insights into How the Dimetal Center in Dihydropyrimidinase Can Bind the Thymine Antagonist 5-Aminouracil: A Different Binding Mode from the Anticancer Drug 5-Fluorouracil.
Lin ES; Luo RH; Yang YC; Huang CY
Bioinorg Chem Appl; 2022; 2022():1817745. PubMed ID: 35198016
[TBL] [Abstract][Full Text] [Related]
17. RNA-based therapeutics for colorectal cancer: Updates and future directions.
Liu J; Guo B
Pharmacol Res; 2020 Feb; 152():104550. PubMed ID: 31866285
[TBL] [Abstract][Full Text] [Related]
18. Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism.
Spanogiannopoulos P; Kyaw TS; Guthrie BGH; Bradley PH; Lee JV; Melamed J; Malig YNA; Lam KN; Gempis D; Sandy M; Kidder W; Van Blarigan EL; Atreya CE; Venook A; Gerona RR; Goga A; Pollard KS; Turnbaugh PJ
Nat Microbiol; 2022 Oct; 7(10):1605-1620. PubMed ID: 36138165
[TBL] [Abstract][Full Text] [Related]
19.
Liu D; Xie L-S; Lian S; Li K; Yang Y; Wang W-Z; Hu S; Liu S-J; Liu C; He Z
mSphere; 2024 Apr; 9(4):e0081623. PubMed ID: 38470044
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyrimidinase from
Quartinello F; Subagia R; Zitzenbacher S; Reich J; Vielnascher R; Becher E; Hall M; Ribitsch D; Guebitz GM
Front Bioeng Biotechnol; 2023; 11():1158226. PubMed ID: 37180040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
